🔗 Share this article

While the United States proceeds with sweeping changes to its vaccine recommendations, an unexpected name has emerged somewhat surprisingly: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and public health researcher who rose to prominence by questioning COVID-19 vaccines in the global health crisis and has zeroed in on potential deaths following Covid immunization in her recent time at the Food and Drug Administration.

Scheduled Shifts to Childhood Immunization Program

Agency leaders were set to unveil radical changes to the childhood vaccination calendar earlier this month, aligning the US with Denmark’s vaccine program, sources say – a major change that would place the US at odds with many the international standard with little proof for improved outcomes. This reveal has been postponed until the next year.

Rather than the top vaccines chief, Dr. Høeg is scheduled to present at the meeting. She was recently named interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to run the center this year.

A Shift at the Agency

Høeg's temporary position could signify a tighter collaboration between the pharmaceutical and vaccine divisions as Dr. Høeg and Dr. Prasad consolidate power at the FDA – and it signals a increased emphasis upon rolling back already-approved immunizations at the FDA.

The new acting director has often pushed for halting certain childhood immunization guidelines in the US in order to be more similar to Denmark's approach, a society with nationalized medicine and a population roughly the size of the state of Wisconsin.

In her initial public appearances, she has kept her attention on vaccination policy – traditionally the purview of Dr. Prasad, chief of the FDA’s CBER – as opposed to medication approval.

Doubts Over Background

The appointee has little discernible background in drug development, oversight or management, which has been standard for previous directors of the biologics center. She has worked at the FDA as a senior adviser to the commissioner and the vaccine center since spring.

“She appears not to have the requisite experience” for overseeing the pharmaceutical oversight division, stated Dr. Jonathan Howard. “She’s never run a scientific study. She is not versed in managing a large organization. She lacks background in pharmaceutical oversight.”

Past commissioners of the center would “be deeply familiar with laws and regulations and the underlying principles of drug development”, said Janet Woodcock. “Frankly, she doesn’t have the kind of background that former directors who led CBER have had.”

CDER has an immense workload at the agency, Woodcock emphasized.

“Everybody just focuses on the novel medication approvals, but the generic program approves numerous generic medications. There is also a biologic copycat branch, over-the-counter program and other areas, and all of those have to be supervised,” she said. “The thing you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Additionally, a major administrative component to the position, which oversees in excess of 5,000 employees. “It’s a massive management job, if you perform it correctly,” Woodcock said.

Agency Reaction and Controversial Policies

Regarding inquiries about Høeg’s credentials and whether this selection signifies greater collaboration among agency officials on vaccines, a representative said that the “questions rely on incorrect assumptions”.

“Her experience aligns with the responsibilities of her job,” the representative explained, citing the time Dr. Høeg spent advising the agency head on “pharmaceutical safety and oversight research, including computational safety modeling and immunization monitoring”.

In her interim role, Høeg inherits the agency head's recently launched expedited review system, a contentious expedited therapy clearance system that reportedly troubled her former heads. “By what process are these medications being picked for this fast-track system? Who takes the choices?” Howard questioned. “There’s a lot of confidentiality happening at the FDA right now.”

Overall, he stated, “the Food and Drug Administration seems to be moving towards less stringent oversight of pharmaceuticals, except for immunizations.”

Established Track Record on Immunizations

Regarding immunizations, Høeg has a more documented, if problematic, track record, some experts said. She released a research paper using non-validated crowd-sourced reports to estimate the frequency of heart inflammation after Covid vaccination. She counseled the state of Florida chief medical officer Dr. Joseph Ladapo, who was said to have changed statistics to indicate Covid vaccines are more dangerous than they are.

Part of her “desired changes” for the current government encompassed revising regulations for recently developed shots and halting “non-essential” immunizations, she said following the vote on a podcast. At the agency, Dr. Høeg has according to sources proposed preventing teenage boys from getting Covid vaccinations.

“She’s an all-around dogmatist who begins with her preconceived notions and works backwards to accommodate the evidence in a highly misleading, untruthful manner,” Howard said.

Taking Control and a “Push for Payback”

Høeg became part of other contrarians, {like|